☆ 4.6 Editorial Material

Immune Checkpoint Inhibition in Metastatic Urothelial Cancer

EUROPEAN UROLOGY (2017)

Get Full Text
Add to Collection

Journal

EUROPEAN UROLOGY
Volume 72, Issue 4, Pages 477-481

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.eururo.2017.03.047

Keywords

-

Categories

Urology & Nephrology

Funding

  1. Bristol-Myers Squibb
  2. Roche
  3. AstraZeneca
  4. Merck
  5. Bayer
  6. Immatics
  7. Novartis
  8. Pfizer

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.